Imaging mass spectrometry reveals modified forms of histone H4 as new biomarkers of microvascular invasion in hepatocellular carcinomas

Microvascular invasion (MiVI) is a major risk factor in postoperative tumor recurrence and mortality in hepatocellular carcinoma (HCC). Unfortunately, this histological feature is usually missed by liver biopsy because of limited sampling, and MiVI is commonly detected only after surgery and examination of the full resected specimen. To date, there exists no reliable tool for identifying MiVI prior to surgical procedures. This study aimed to compare the proteome of HCC with and without MiVI in order to identify surrogate biomarkers of MiVI. A training cohort comprising surgically resected primary HCC with MiVI (n = 30) and without MiVI (n = 26) was subjected to matrix‐assisted laser desorption ionization imaging mass spectrometry (MALDI IMS). Comparative analysis of acquired mass spectra of the two groups yielded 30 differential protein peaks, among which 28 were more strongly expressed in HCC with MiVI. Among these, two peaks were identified as N‐term acetylated histone H4 dimethylated at lysine (K) 20, and N‐term acetylated histone H4 dimethylated at K20 and acetylated at K16. Both peaks were validated in the training cohort and in an independent validation cohort (n = 23) by immunohistochemistry and western blot. Conclusion: These results demonstrate the potential of MALDI IMS for uncovering new relevant biomarkers of MiVI in HCC, and highlight the role of epigenetic modifications in the prognosis of HCC. Preoperative detection of modified forms of histone H4 expression in tumor biopsies would be helpful in management of patients with HCC. (Hepatology 2013;53:983–994)

[1]  Marius Ueffing,et al.  Tissue‐based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer , 2012, The Journal of pathology.

[2]  Theodore Alexandrov,et al.  New analysis workflow for MALDI imaging mass spectrometry: application to the discovery and identification of potential markers of childhood absence epilepsy. , 2012, Journal of proteome research.

[3]  S. Rauser,et al.  Direct molecular tissue analysis by MALDI imaging mass spectrometry in the field of gastrointestinal disease. , 2012, Gastroenterology.

[4]  D. Xie,et al.  High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma. , 2012, Human pathology.

[5]  Jian-Bing Fan,et al.  Gene-expression signature of vascular invasion in hepatocellular carcinoma. , 2011, Journal of hepatology.

[6]  P. Chow,et al.  Microvascular Invasion Is a Better Predictor of Tumor Recurrence and Overall Survival Following Surgical Resection for Hepatocellular Carcinoma Compared to the Milan Criteria , 2011, Annals of surgery.

[7]  Jean-Michel Camadro,et al.  Imaging mass spectrometry provides fingerprints for distinguishing hepatocellular carcinoma from cirrhosis. , 2011, Journal of proteome research.

[8]  Richard M Caprioli,et al.  MALDI imaging mass spectrometry of human tissue: method challenges and clinical perspectives. , 2011, Trends in biotechnology.

[9]  Y. Zeng,et al.  High Expression of H 3 K 27 me 3 in Human Hepatocellular Carcinomas Correlates Closely with Vascular Invasion and Predicts Worse Prognosis in Patients , 2011 .

[10]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[11]  Kristina Schwamborn,et al.  Molecular imaging by mass spectrometry — looking beyond classical histology , 2010, Nature Reviews Cancer.

[12]  Lisa H Cazares,et al.  Imaging Mass Spectrometry of a Specific Fragment of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase Kinase 2 Discriminates Cancer from Uninvolved Prostate Tissue , 2009, Clinical Cancer Research.

[13]  Daniele Soria,et al.  Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. , 2009, Cancer research.

[14]  Bart J. A. Mertens,et al.  Biomarker discovery in MALDI-TOF serum protein profiles using discrete wavelet transformation , 2009, Bioinform..

[15]  L. Mariani,et al.  Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. , 2009, The Lancet. Oncology.

[16]  G. Schotta,et al.  A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse. , 2008, Genes & development.

[17]  M. Sata,et al.  Microvascular Invasion in Patients with Hepatocellular Carcinoma and Its Predictable Clinicopathological Factors , 2008, Annals of Surgical Oncology.

[18]  T. Ludwig,et al.  The Mammalian Ortholog of Drosophila MOF That Acetylates Histone H4 Lysine 16 Is Essential for Embryogenesis and Oncogenesis , 2007, Molecular and Cellular Biology.

[19]  C. Allis,et al.  Chromatin remodeling and cancer, Part I: Covalent histone modifications. , 2007, Trends in molecular medicine.

[20]  T. Kouzarides.  Chromatin Modifications and Their Function , 2007, Cell.

[21]  Georges Mer,et al.  Structural Basis for the Methylation State-Specific Recognition of Histone H4-K20 by 53BP1 and Crb2 in DNA Repair , 2006, Cell.

[22]  M. Ho,et al.  A Gene Expression Profile for Vascular Invasion can Predict the Recurrence After Resection of Hepatocellular Carcinoma: a Microarray Approach , 2006, Annals of Surgical Oncology.

[23]  M. Pazin,et al.  Histone H4-K16 Acetylation Controls Chromatin Structure and Protein Interactions , 2006, Science.

[24]  Yu Shyr,et al.  Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry. , 2005, Cancer research.

[25]  Timothy M Pawlik,et al.  Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[26]  S. Horvath,et al.  Global histone modification patterns predict risk of prostate cancer recurrence , 2005, Nature.

[27]  M. Fraga,et al.  Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer , 2005, Nature Genetics.

[28]  S. Kawasaki,et al.  Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. , 2003, Journal of hepatology.

[29]  R. Brachmann,et al.  Chromatin Remodeling and Cancer , 2003, Cancer biology & therapy.

[30]  P Neuhaus,et al.  Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis , 2001, Hepatology.

[31]  M. Stoeckli,et al.  Imaging mass spectrometry: A new technology for the analysis of protein expression in mammalian tissues , 2001, Nature Medicine.

[32]  ndrea,et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.

[33]  M. Manns,et al.  Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  R. Caprioli,et al.  Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. , 1997, Analytical chemistry.

[35]  G. Dusheiko,et al.  Management of hepatocellular carcinoma. , 1992, Journal of hepatology.